FSCS:NSD-First Trust SMID Capital Strength ETF (USD)

ETF | Others |

Last Closing

USD 35.62

Change

-0.06 (-0.15)%

Market Cap

USD 0.04B

Volume

6.45K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-1.77 (-2.97%)

USD 65.59B
QQQM Invesco NASDAQ 100 ETF

-1.66 (-0.76%)

USD 46.74B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.19 (-0.36%)

USD 25.59B
ACWI iShares MSCI ACWI ETF

-0.37 (-0.30%)

USD 21.43B
CGABL The Carlyle Group Inc. 4.625% ..

-0.01 (-0.06%)

USD 16.14B
TSLL Direxion Shares ETF Trust - Di..

-3.91 (-28.50%)

USD 6.20B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.83B
ETHA iShares Ethereum Trust ETF

-0.73 (-3.67%)

USD 3.58B
NVDL GraniteShares 1.5x Long NVDA D..

-1.57 (-2.73%)

USD 3.52B
MAGS Roundhill Magnificent Seven ET..

-1.39 (-2.63%)

USD 2.32B

ETFs Containing FSCS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.59% 54% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.59% 52% F 61% D-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.04B 54% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike